Cargando…
Prognostic value of multiple repeated biomarkers in pulmonary arterial hypertension associated with congenital heart disease
Autores principales: | van Dissel, Alexandra C., Blok, Ilja M., Zwinderman, Aeilko H., van Dijk, Arie P.J., Duijnhouwer, Anthonie L., de Winter, Robbert J., Mulder, Barbara J.M., Bouma, Berto J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607513/ https://www.ncbi.nlm.nih.gov/pubmed/30520544 http://dx.doi.org/10.1002/ejhf.1363 |
Ejemplares similares
-
The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017) -
High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality
por: Woudstra, Odilia I, et al.
Publicado: (2019) -
Medication in adults after atrial switch for transposition of the great arteries: clinical practice and recommendations
por: Woudstra, Odilia I, et al.
Publicado: (2020) -
Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity
por: Winter, Michiel M, et al.
Publicado: (2008) -
Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan
por: Schuuring, Mark J, et al.
Publicado: (2010)